Dexcom (DXCM) Change in Receivables (2010 - 2026)

Dexcom (DXCM) has reported Change in Receivables for 17 consecutive years, with $172.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Receivables fell 6.77% year-over-year to $172.1 million in Q2 2026; TTM through Jun 2026 was -$84.1 million, a 121.21% decrease from a year earlier, with the FY2025 full-year figure at $201.9 million, up 476.86% from the prior year.
• Change in Receivables was $172.1 million for Q2 2026 at Dexcom, up from -$124.6 million in the prior quarter.
• Over five years, Change in Receivables peaked at $187.2 million in Q4 2023 and troughed at -$237.8 million in Q3 2025.
• A 5-year average of $41.4 million and a median of $32.9 million in 2022 frame the typical range for Change in Receivables.
• The widest YoY moves for Change in Receivables: up 2467.24% in 2025, down 527.7% in 2025.
• Over 5 years, Change in Receivables stood at $148.3 million in 2022, then grew by 26.23% to $187.2 million in 2023, then slumped by 96.05% to $7.4 million in 2024, then surged by 1335.14% to $106.2 million in 2025, then jumped by 62.05% to $172.1 million in 2026.
• The last three Change in Receivables figures came in at $172.1 million (Q2 2026), -$124.6 million (Q1 2026), and $106.2 million (Q4 2025), per Business Quant data.